Liraglutide (TFA)

Produktübersicht

• Artikelname: Liraglutide (TFA)
• Artikelnummer: MCE-HY-P0014B
• Hersteller Artikelnummer: HY-P0014B
• Alternativnummer: MCE-HY-P0014B-10MG,MCE-HY-P0014B-1MG,MCE-HY-P0014B-5MG
• Hersteller: MedchemExpress
• Kategorie: Proteine/Peptide

Produktbeschreibung

Liraglutide (TFA) is an agonist of glucagon-like peptide 1 receptor (GLP-1). Liraglutide (TFA) can activate GLP-1, leading to the release of insulin in the presence of increased glucose concentration. Liraglutide (TFA) also reduces glucagon secretion in a glucose-dependent manner. Liraglutide (TFA) can be studied in research on type 2 diabetes[1].

Produkteigenschaften

• Molekulargewicht: 3751.20 (free base)
• Reinheit: 99.56
• Formel: C172H265N43O51.xC2HF3O2
• Target-Kategorie: GLP Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: Peptides